Press Releases

SHENZHEN, China, April 30, 2024 /PRNewswire/ -- Organised by RX (China), WEPACK World Expo of Packaging Industry has successfully concluded at Shenzhen World Exhibition & Convention Center on April 12th. Thanks to the robust development of the packaging industry and concerted efforts from 1200+ exhibitors for three days, the exhibition's debut in Shenzhen lived up to expectations.

Over the exhibition of three days, WEPACK 2024, along with its six major series... (continue reading...)

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Exscientia plc (NASDAQ: EXAI) securities between March 23, 2022 and February 12, 2024. Exscientia in an artificial intelligence (“AI”) driven Pharma-tech company that engages in the design and develop differentiated medicines for diseases with high unmet patient needs.

For... (continue reading...)

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Akero Therapeutics, Inc. (NASDAQ: AKRO) securities between September 13, 2022 and October 9, 2023. Akero is a clinical stage biopharmaceutical company that was founded to develop transformational medicines for patients with serious metabolic diseases that lack effective treatment... (continue reading...)

Dividend amount: NOK 2.5 per shareDeclared currency: NOKLast day including right: 28 May 2024Ex-date: 29 May 2024Record date: 30 May 2024Payment date: 5 June 2024Date of approval: 28 May 2024

This information is published in accordance with the requirements of the Oslo Børs Rule Book II section 4.2.4 (1) no. 3.

SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, today announces the appointment of Dr. Samuel Zhang as its Global Chief Business Officer (CBO). In this role, Dr. Zhang will be... (continue reading...)